Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,824 stories, page 476 of 698

Advanced search

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

FDA clarifies false positive for Cyclospora in Taylor Farms lettuce; nationwide recall in effect.

facebook.comOriginal source

🇯🇵Jul 20Researchriken.jpTier 2 · Direct publisher

Meet RIKEN's new laboratory heads (July 2026)

RIKENOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Phase 3 trial tests antibody therapy to prevent blood cancer infections

Rare Cancer NewsOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

US Naproxen Prices Expected to Remain Firm Amid Resilient Pharmaceutical Demand

ChemAnalystOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Biovica comments on ninth order from leading pharmaceutical customer

BiostockOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Q&A: Psychedelics, cannabis, GLP-1s and drug policy changes

Medical XpressOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

APhA urges FDA to put patient safety first in review of peptide substances

Chain Drug ReviewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Judge Tosses Vanda’s Fight Against FDA’s Drug Approval Structure

Bloomberg Law NewsOriginal source

🌍Jul 20Industryabelzeta.comTier 1 · Company source

AbelZeta Receives EMA PRIME Designation for C-CAR168 in Lupus Nephritis and Systemic Lupus Erythematosus

AbelZeta PharmaOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Resmed ventilator safety issue linked to 5 serious injuries

MedTech DiveOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Practical Guidance for Pharmaceutical Method-of-Use Patent Claims After Teva v. Eli Lilly and In re Xencor

Foley & Lardner LLPOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

FDA’s adequate provision rule proposal could accelerate pharma’s transition away from TV

Campaign USOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Dianthus Therapeutics Stock Surges After Initiating Major Phase 3 Clinical Trial

TIKR.comOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

Tempus buys out cancer genomics specialist Personalis in $1.5 billion deal

Fierce BiotechOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

Scribe aims for $96M IPO to fund lipid-lowering genetic meds

Fierce BiotechOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Unfamiliar odor caused large EMS response at Grifols pharmaceutical plant in Clayton

WRALOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

A most-wanted fugitive appears to have been secretly working as a biotech executive

STATOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

What Cold Chain Tech Trends Are Reshaping Pharma Logistics?

Pharmaceutical CommerceOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

930 Dead in Outbreak; FDA Backtracks on Iceberg Lettuce; Chronic Cough Drug Fizzles

MedPage TodayOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test

Fierce BiotechOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

FDA Reverses Positive Cyclospora Lettuce Test Result as Taylor Farms Recall Stays in Effect Nationwide

International Business Times AustraliaOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating

marketscreener.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

NuCana stock holds value as cash runway and clinical pipeline shape outlook

ad-hoc-news.deOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

U.S. Food And Drug Administration Apologizes to Taylor Farms For False Cyclospora Test Results

TMZOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Acadia Expects Topline Alzheimer's Psychosis Results Sept.-Oct. 2026

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Biotech Pre-Market Pulse: ADVB, CAMP Swing Big; BIVI Drops

RTTNewsOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Investigational anal cancer therapy posts 30% response rate

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer

GlobeNewswireOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Global Health Advances: A Dive into Breakthroughs and Challenges

DevdiscourseOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

FDA: Taylor Farms lettuce cyclospora finding was false positive

The HillOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Samsung Biologics to buy PolyPeptide for $1.9 bn in Korea’s biggest pharma deal

KED GlobalOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

UK biotech financing continues growth, reaching five-year high

FirstWord PHARMAOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk launches cheaper Ozempic copy in South Africa

medwatch.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln

Yahoo FinanceOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans

Yahoo! Finance CanadaOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Keeping drugs free of contaminants – pharmaceutical manufacturers filter medications through tiny pores to keep them sterile and safe

The Elkhart TruthOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Q2 2026 Preview: EPS Est. $2.08, Reports July 23

AlphaStreetOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Keeping drugs free of contaminants – pharmaceutical manufacturers filter medications through tiny pores to keep them sterile and safe

The ConversationOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Nuvation CEO David Hung Details Leadership Strategies and Career Motivations in Biotech

geneonline.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Rohto Pharmaceutical Co., Ltd. – GETTEX:UC1

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene’s knee osteoarthritis therapy fails phase 3 trial By Investing.com

Investing.com CanadaOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

US Fusidic Acid Prices Decline 13.31% Amid Soft Pharmaceutical Demand

ChemAnalystOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

FDA says positive cyclospora test on Taylor Farms lettuce was an error. The multistate sickness outbreak continues.

Yahoo Life UKOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene Reports Topline ACTiVION-II Phase 3 Clinical Trial Results for TissueGene-C (TG-C) Targeting Osteoarthritis (OA) of the Knee

The Manila TimesOriginal source

🇪🇸Jul 20Researchcnio.esTier 2 · Direct publisher

MamoRisk project to validate in Spain a new breast cancer risk prediction model

CNIO (Spain Cancer News)Original source

🇨🇦Jul 20Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Philips Achieva and Ingenia Systems

Philips has identified an issue where component failures in the gradient coil of the affected MR sys...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

After More Than 20 Years, Collegium Plans Boston Headquarters Move

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Tinlarebant retinal marker stayed stable or fell ~2%; placebo rose 20%

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

Yahoo! Finance CanadaOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Biotech is booming this year: 2 reasons investors are excited

Yahoo FinanceOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Is Taylor Farms Lettuce Safe? FDA Retracts Positive Cyclospora Test Result

International Business Times, Singapore EditionOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Tian'an Pharmaceutical Co., Ltd. – OTC:TNPH

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

Geopolitics ‘chills’ British biotech IPO plans, despite $2B in Q2 VC funds

Fierce BiotechOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Armata Advances AP-SA02 Toward Phase 3 Trial Launch

TipRanksOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Buy on 4D Molecular stock on trial data

Investing.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma (Nasdaq: OKYO) highlights cash for NEPTUNE Phase 3

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Biohaven’s BHV-1530 targets FGFR3 tumors with or without alterations

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Applications open for Biotech Certified Innovation Path

fundsforNGOsOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma Files Annual Report and Provides Positive Corporate Update on Financial Strength and Phase 3 Urcosimod Trial

Quiver QuantitativeOriginal source